Spots Global Cancer Trial Database for description of the molecular alterations detected in blood samples of patients treated by osimertinib
Every month we try and update this database with for description of the molecular alterations detected in blood samples of patients treated by osimertinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Resistance to Oral Therapy in Lung Cancer | NCT04546282 | Non Small Cell ... | Description of ... | 18 Years - 90 Years | University Hospital, Montpellier |